Global Medical Grade Chitosan Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Medical Grade Chitosan Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.
Medical Grade Chitosan report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Grade Chitosan market is projected to reach US$ 58 million in 2034, increasing from US$ 34 million in 2022, with the CAGR of 7.8% during the period of 2024 to 2034. Demand from Wound Care and Healthcare Products are the major drivers for the industry.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Grade Chitosan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Wound Care
Healthcare Products
Antibacterial Products
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Grade Chitosan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Grade Chitosan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Grade Chitosan industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Grade Chitosan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Grade Chitosan introduction, etc. Medical Grade Chitosan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Medical Grade Chitosan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Medical Grade Chitosan report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Medical Grade Chitosan market is projected to reach US$ 58 million in 2034, increasing from US$ 34 million in 2022, with the CAGR of 7.8% during the period of 2024 to 2034. Demand from Wound Care and Healthcare Products are the major drivers for the industry.
The industry's leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Medical Grade Chitosan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry
Segment by Type
Animal Origin Chitosan
Plant Based Chitosan
Segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Medical Grade Chitosan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Medical Grade Chitosan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Medical Grade Chitosan industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Medical Grade Chitosan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Medical Grade Chitosan introduction, etc. Medical Grade Chitosan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Medical Grade Chitosan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices